2024 Speakers

Adam Smith

Director

Telix Pharmaceuticals

Amir Golan

Vice President - Radioligand Therapy Platform

Novartis

Amir Iravani

Associate Professor

University of Washington- Fred Hutchinson Cancer Center, Seattle, WA

Amos Hedt

Chief Business Officer

Perspective Therapeutics

Andreas Goutopoulos

ceo

Actithera

Andrew Thompson

Radiation Oncologist

Beaumont Health System

Anna Karmann

Chief Medical Officer

AdvanCell

Brigitte Thériault

Sr. Director, Biology

Fusion Pharmaceuticals

Charles Vriamont

Scientific Collaboration Manager

Trasis

Chris Lowe

Chief Executive Officer

Nusano

Daniel Thorek

Associate Professor

Washington University School of Medicine in St. Louis

Danielle Meyrick

Chief Medical Officer

ITM

Darshan Dalal

Global Product Leader

AstraZeneca

David Ulmert

Director

University of California Los Angeles

Elcin Zan

Assistant Professor

Cleveland Clinic

Jack Hoppin

Chief Executive Officer

Ratio Therapeutics

Jacob Houghton

Assistant Professor

Stony Brook School of Medicine

Jarrod Longcor

Chief Operating Officer

Cellectar Biosciences Inc.

Jeremie Calais

MD

University of California Los Angeles

Jones Nauseef

Senior Medical Director

Convergent Therapeutics

Josh Mailman

President

NorCal CarciNET

Joshua Apgar

Co-Founder & Chief Scientific Officer

Applied BioMath

Kemp Dolliver

Director of Research and Senior Analyst

Brookline Capital Markets

Kurt Hoeprich

Head of Global Sales

SHINE Technologies

Manfred Rüdiger

Chief Executive Officer

Ariceum Therapeutics

Mary Jessel

Senior Vice President - Global Medical Affairs

Telix Pharmaceuticals

Matthew Korn

Global Medical Lead

Bayer

Michael Nickels

Director - Cyclotron Facility

Washington University School of Medicine in St. Louis

Mike Wardach

VP, Regulatory Affairs

Z-Alpha Therapeutics

Nadine Mallak

Associate & Assistant Professor

OHSU - Oregon Health & Science University

Nicholas Pullen

CSO

ARTBIO

Othon Gervasio

Senior Director - Medical

Clarity Pharmaceuticals

Reinier Hernandez

Assistant Professor

University of Wisconsin-Madison

Sarah Cheal

Assistant Professor

Cornell University

Scott Tagawa

Professor

Weill Cornell University

Sergio Calvo,

Global General Manager, Theranostics

GE Healthcare

Shankar Vallabhajosula

Vice President, Radiopharmaceutical Sciences

Convergent Therapeutics

Simon Read

Founder & Chief Executive Officer

Mariana Oncology

Sirmon Singh

Med Onc

Sunnybrook Research Institute

Sven Van den Berghe

Chief Executive Officer

PANTERA

Tobias Heinrich

Head of Laboratory in Medicinal Chemistry

Bayer

Volker Wagner

Chief Medical Officer

OranoMed

Zachary Morris

Associate Professor and Vice-Chair

University of Wisconsin-Madison